InvestorsHub Logo
Followers 2
Posts 304
Boards Moderated 0
Alias Born 03/27/2018

Re: Classic Warrior post# 35687

Friday, 05/12/2023 5:37:03 PM

Friday, May 12, 2023 5:37:03 PM

Post# of 36602
about the only good thing I see here is that with the data being unblinded (and I agree that they had looked at the 210 and 500ish) maybe a 'partner' that they may be talking to can now discuss with the FDA an agreement on a fresh study / endpoints and hopefully that partner has the expertise to run a fairly quick trial under new endpoints, Basically they waited too long the trial fizzled with no push towards enrollment.

I agree with you - no sense pulling the trigger here - I'll just hold tight and see what the next 3 - 5 years bring.